Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JP. Balgobind BV, et al. Among authors: van den heuvel eibrink mm, van den ouweland am, van wering er, van vlierberghe p. Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2. Blood. 2008. PMID: 18172006 Free article.
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J, Passier M, van Wering ER, Veerman AJ, Kamps WA, Meijerink JP, Pieters R. Van Vlierberghe P, et al. Among authors: van grotel m, van wering er. Blood. 2006 Nov 15;108(10):3520-9. doi: 10.1182/blood-2006-04-019927. Epub 2006 Jul 27. Blood. 2006. PMID: 16873670 Free article.
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP. Van Vlierberghe P, et al. Among authors: van grotel m, van der spek pj, van wering er. Blood. 2008 May 1;111(9):4668-80. doi: 10.1182/blood-2007-09-111872. Epub 2008 Feb 25. Blood. 2008. PMID: 18299449 Free PMC article.
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
Balgobind BV, Van den Heuvel-Eibrink MM, De Menezes RX, Reinhardt D, Hollink IH, Arentsen-Peters ST, van Wering ER, Kaspers GJ, Cloos J, de Bont ES, Cayuela JM, Baruchel A, Meyer C, Marschalek R, Trka J, Stary J, Beverloo HB, Pieters R, Zwaan CM, den Boer ML. Balgobind BV, et al. Among authors: van wering er. Haematologica. 2011 Feb;96(2):221-30. doi: 10.3324/haematol.2010.029660. Epub 2010 Oct 22. Haematologica. 2011. PMID: 20971820 Free PMC article.
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.
Zwaan CM, Reinhardt D, Corbacioglu S, van Wering ER, Bökkerink JP, Tissing WJ, Samuelsson U, Feingold J, Creutzig U, Kaspers GJ. Zwaan CM, et al. Among authors: van wering er. Blood. 2003 May 15;101(10):3868-71. doi: 10.1182/blood-2002-07-1947. Epub 2003 Jan 23. Blood. 2003. PMID: 12543868 Free article. Clinical Trial.
Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Van Vlierberghe P, Homminga I, Zuurbier L, Gladdines-Buijs J, van Wering ER, Horstmann M, Beverloo HB, Pieters R, Meijerink JP. Van Vlierberghe P, et al. Among authors: van wering er. Leukemia. 2008 Apr;22(4):762-70. doi: 10.1038/sj.leu.2405082. Epub 2008 Jan 10. Leukemia. 2008. PMID: 18185524
182 results